Evidence map›Paper›PMID 40270990›Full record

ArticleOrganic process research & development2025

Surface Defects and Crystal Growth of Apremilast Benzoic Acid Cocrystals.

Jan Jirát, Vít Zvoníček, Luděk Ridvan, Miroslav Šoóš

Abstract read
In one paragraph

Article in Organic process research & development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jan JirátDepartment of Chemical Engineering, University of Chemistry and Technology, Technicka 3, Prague 6,Dejvice 166 28, Czech Republic.
Vít ZvoníčekDepartment of Chemical Engineering, University of Chemistry and Technology, Technicka 3, Prague 6,Dejvice 166 28, Czech Republic.
Luděk RidvanZentiva, k.s., U kabelovny 130, Prague 10 10237, Czech Republic.
Miroslav ŠoóšDepartment of Chemical Engineering, University of Chemistry and Technology, Technicka 3, Prague 6,Dejvice 166 28, Czech Republic.ORCID https://orcid.org/0000-0002-9742-7160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cocrystallization process of the active pharmaceutical ingredient apremilast with benzoic acid is explored in this work. The aim of the study is to adjust operating conditions during the crystallization to purposefully tune the dissolution properties of the final product. Understanding the cocrystallization is key to obtaining a consistent, high-quality product, as well as tuning other properties such as powder flowability or dissolution properties. It was discovered early in development that the studied cocrystallization process does not follow the common rules of crystallization. Better crystals were obtained at faster cooling rates and worse crystals at slower cooling rates. Interestingly, this can be explained by crystal collisions and a two-phase growth of the crystals. Standard operating conditions were further tested, resulting in different shapes and sizes of the product. Different types of produced crystals were tested in a dissolution apparatus and provided significantly modified dissolution profiles.

Identifiers

PMID40270990
PMCPMC12012881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.